Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Caffarel MM"'
Autor:
Feiner, IVJ, Pulagam, KR, Gómez‐Vallejo, V, Zamacola, K, Baz, Z, Caffarel, MM, Lawrie, CH, Ruiz‐de‐Angulo, A, Carril, M, Llop, J.
Boron neutron capture therapy (BNCT) is a binary approach for cancer treatment in which boron-10 atoms and thermal neutrons need to colocalize to become effective. Recent research in the development of BNCT drug candidates focuses increasingly on nan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::56c07e35951ab5332885bc1bd3803797
https://zenodo.org/record/4556861
https://zenodo.org/record/4556861
Autor:
Isabel García-Real, José Palacios, Cristina Sánchez, Clara Andradas, Manuel Guzmán, Gema Moreno-Bueno, María M. Caffarel, Emilia Mira, Santos Mañes, Eduardo Pérez-Gómez, Camilla Cerutti, Juana M. Flores
Publikováno v:
Molecular Cancer
Digital.CSIC. Repositorio Institucional del CSIC
instname
Molecular Cancer, Vol 9, Iss 1, p 196 (2010)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Molecular Cancer, Vol 9, Iss 1, p 196 (2010)
This is an Open Access article distributed under the terms of the Creative Commons Attribution License.-- et al.
[Background]: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard t
[Background]: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b36c89d9156c81259856ab6e154659
https://hdl.handle.net/10668/1668
https://hdl.handle.net/10668/1668
Autor:
Bakhshandeh S; Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany., Heras U; Group of Bioengineering in Regeneration and Cancer, Biogipuzkoa Health Research Institute, San Sebastian, Spain.; Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain., Taïeb HM; Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany., Varadarajan AR; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Lissek SM; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany., Hücker SM; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Lu X; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Garske DS; Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany., Young SAE; Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany., Abaurrea A; Group of Breast Cancer, Biogipuzkoa Health Research Institute, San Sebastian, Spain., Caffarel MM; Group of Breast Cancer, Biogipuzkoa Health Research Institute, San Sebastian, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain., Riestra A; Department of Pharmacy, Fundación Onkologikoa Fundazioa, San Sebastian, Spain.; Department of Medicine, University of Deusto, Bilbao, Spain., Bragado P; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.; Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain., Contzen J; Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Active Polymers, Helmholtz-Zentrum Hereon, Teltow, Germany.; Berlin-Brandenburg Center for Regenerative Therapies, Charité Campus Virchow Klinikum, Berlin, Germany., Gossen M; Institute of Active Polymers, Helmholtz-Zentrum Hereon, Teltow, Germany.; Berlin-Brandenburg Center for Regenerative Therapies, Charité Campus Virchow Klinikum, Berlin, Germany., Kirsch S; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Warfsmann J; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Honarnejad K; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Klein CA; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany.; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany., Cipitria A; Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.; Group of Bioengineering in Regeneration and Cancer, Biogipuzkoa Health Research Institute, San Sebastian, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
Publikováno v:
Science advances [Sci Adv] 2024 Nov 08; Vol. 10 (45), pp. eadr3997. Date of Electronic Publication: 2024 Nov 06.
Autor:
Bacci M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Lorito N; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Smiriglia A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Subbiani A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Bonechi F; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Comito G; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Morriset L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005 Paris, France., El Botty R; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005 Paris, France., Benelli M; Department of Medical Oncology, Azienda USL Toscana Centro, Hospital of Prato, Via Suor Niccolina Infermiera 20, 59100 Prato, Italy., López-Velazco JI; Biodonostia Health Research Institute, Paseo Dr Begiristain s/n, 20014 San Sebastian, Spain., Caffarel MM; Biodonostia Health Research Institute, Paseo Dr Begiristain s/n, 20014 San Sebastian, Spain.; Ikerbasque, Basque Foundation for Science, Plaza Euskadi 5, 48009 Bilbao, Spain., Urruticoechea A; Biodonostia Health Research Institute, Paseo Dr Begiristain s/n, 20014 San Sebastian, Spain.; Gipuzkoa Cancer Unit, OSI Donostialdea-Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014 San Sebastian, Spain., Sflomos G; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland., Malorni L; Department of Medical Oncology, Azienda USL Toscana Centro, Hospital of Prato, Via Suor Niccolina Infermiera 20, 59100 Prato, Italy., Corsini M; Department of Molecular and Translational Medicine, University of Brescia, Via Branze 39, 25123 Brescia, Italy., Ippolito L; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Giannoni E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Meattini I; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Largo Brambilla 3, 50134 Florence, Italy., Matafora V; IFOM ETS-AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy., Havas K; IFOM ETS-AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy., Bachi A; IFOM ETS-AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy., Chiarugi P; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy., Marangoni E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005 Paris, France., Morandi A; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Feb 28; Vol. 16 (736), pp. eadf9874. Date of Electronic Publication: 2024 Feb 28.
Autor:
López-Velazco JI; Biogipuzkoa (Previously Known As Biodonostia) Health Research Institute, Paseo Dr Begiristain S/N, 20014, San Sebastian, Spain., Manzano S; Biogipuzkoa (Previously Known As Biodonostia) Health Research Institute, Paseo Dr Begiristain S/N, 20014, San Sebastian, Spain., Otaño M; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain., Elorriaga K; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain., Bultó N; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain., Herrero J; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain., Lahuerta A; Biogipuzkoa (Previously Known As Biodonostia) Health Research Institute, Paseo Dr Begiristain S/N, 20014, San Sebastian, Spain.; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain., Segur V; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain., Álvarez-López I; Biogipuzkoa (Previously Known As Biodonostia) Health Research Institute, Paseo Dr Begiristain S/N, 20014, San Sebastian, Spain.; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain., Caffarel MM; Biogipuzkoa (Previously Known As Biodonostia) Health Research Institute, Paseo Dr Begiristain S/N, 20014, San Sebastian, Spain. MARIA.MUNOZCAFFAREL@biodonostia.org.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain. MARIA.MUNOZCAFFAREL@biodonostia.org., Urruticoechea A; Biogipuzkoa (Previously Known As Biodonostia) Health Research Institute, Paseo Dr Begiristain S/N, 20014, San Sebastian, Spain. aurruticoechea@onkologikoa.org.; Gipuzkoa Cancer Unit, OSI Donostialdea - Onkologikoa Foundation, Paseo Dr Begiristain 121, 20014, San Sebastian, Spain. aurruticoechea@onkologikoa.org.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Jan 03; Vol. 26 (1), pp. 3. Date of Electronic Publication: 2024 Jan 03.
Autor:
Soler MF; Biogipuzkoa (previously known as Biodonostia) Health Research Institute, Donostia-San Sebastian, Spain., Abaurrea A; Biogipuzkoa (previously known as Biodonostia) Health Research Institute, Donostia-San Sebastian, Spain., Azcoaga P; Biogipuzkoa (previously known as Biodonostia) Health Research Institute, Donostia-San Sebastian, Spain., Araujo AM; Biogipuzkoa (previously known as Biodonostia) Health Research Institute, Donostia-San Sebastian, Spain., Caffarel MM; Biogipuzkoa (previously known as Biodonostia) Health Research Institute, Donostia-San Sebastian, Spain maria.munozcaffarel@biodonostia.org.; Ikerbasque Basque Foundation for Science, Bilbao, Spain.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Nov; Vol. 11 (11).
Autor:
Tundidor I; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Seijo-Vila M; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Blasco-Benito S; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Rubert-Hernández M; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain., Adámez S; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain., Andradas C; Brain Tumor Research Program, Telethon Kids Institute, Nedlands, WA, Australia.; Centre for Child Health Research, University of Western Australia, Nedlands, WA, Australia., Manzano S; Breast Cancer Group, Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain., Álvarez-López I; Breast Cancer Group, Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain.; Gipuzkoa Cancer Unit, OSI Donostialdea-Onkologikoa Foundation, San Sebastián, Spain., Sarasqueta C; Unit of Information and Healthcare Results, OSI Donostialdea, Biodonostia Health Research Institute, San Sebastián, Spain.; Methodological Support Unit, Biodonostia Health Research Institute, San Sebastián, Spain., Villa-Morales M; Centro de Biología Molecular Severo Ochoa (CBMSO) (CSIC-UAM), Madrid, Spain.; Department of Biology, Autonomous University of Madrid, Madrid, Spain., González-Lois C; Department of Pathology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Ramírez-Medina E; Department of Obstetrics & Gynecology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Almoguera B; Department of Obstetrics & Gynecology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Sánchez-López AJ; Biobank Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Madrid, Spain., Bindila L; Clinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center, Mainz, Germany., Hamann S; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany., Arnold N; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany., Röcken C; Institute of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany., Heras-Murillo I; Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Sancho D; Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Moreno-Bueno G; MD Anderson International Foundation; Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM); Department of Biochemistry, Autonomous University of Madrid; Instituto de Investigación Hospital Universitario La Paz (IdiPaz); Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Caffarel MM; Breast Cancer Group, Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain.; Ikerbasque-Basque Foundation for Science, Bilbao, Spain., Guzmán M; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria y Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Sánchez C; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain. macsanch@ucm.es.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. macsanch@ucm.es., Pérez-Gómez E; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain. eduperez@ucm.es.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. eduperez@ucm.es.
Publikováno v:
Nature communications [Nat Commun] 2023 May 30; Vol. 14 (1), pp. 3130. Date of Electronic Publication: 2023 May 30.
Autor:
Serna L; Faculty of Science and Technology, Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), Leioa, Spain., Azcoaga P; Oncology Department, Biodonostia Health Research Institute, San Sebastian, Spain., Brahmachary M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, United States., Caffarel MM; Oncology Department, Biodonostia Health Research Institute, San Sebastian, Spain.; Ikerbasque Basque Foundation for Science, Bilbao, Spain., Braza MS; Oncology Department, Biodonostia Health Research Institute, San Sebastian, Spain.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, United States.; Ikerbasque Basque Foundation for Science, Bilbao, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 May 02; Vol. 14, pp. 1048567. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).
Autor:
Caffarel MM; Biodonostia Health Research Institute, Basque Country, Spain.; Ikarbasque, Basque Foundation for Science, Basque Country, Spain., Braza MS; Biodonostia Health Research Institute, Basque Country, Spain. mounia.braza@mssm.edu.; Ikarbasque, Basque Foundation for Science, Basque Country, Spain. mounia.braza@mssm.edu.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. mounia.braza@mssm.edu.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Nov 21; Vol. 41 (1), pp. 327. Date of Electronic Publication: 2022 Nov 21.
Autor:
Araujo AM, Abaurrea A, Azcoaga P, López-Velazco JI, Manzano S, Rodriguez J, Rezola R, Egia-Mendikute L, Valdés-Mora F, Flores JM, Jenkins L, Pulido L, Osorio-Querejeta I, Fernández-Nogueira P, Ferrari N, Viera C, Martín-Martín N, Tzankov A, Eppenberger-Castori S, Alvarez-Lopez I, Urruticoechea A, Bragado P, Coleman N, Palazón A, Carracedo A, Gallego-Ortega D, Calvo F, Isacke CM, Caffarel MM, Lawrie CH
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2022 Oct 03; Vol. 132 (19). Date of Electronic Publication: 2022 Oct 03.